Why is Colgate-Palmoliv falling/rising?

Recent Price Movement and Market Context

The stock’s downward trajectory is evident in its recent returns, which have significantly lagged behind the broader market indices. Over the past week, Colgate-Palmolive’s shares fell by 3.78%, compared to a modest 0.59% decline in the Sensex. The underperformance extends over longer periods, with the stock down 4.46% in the last month while the Sensex gained 1.34%. Year-to-date, the stock has declined by 21.61%, contrasting sharply with the Sensex’s 8.92% rise. Over the last year, the stock’s return was negative 27.48%, whereas the Sensex appreciated by 5.27%. This persistent underperformance highlights investor concerns about the company’s growth prospects and valuation.

On the day of the decline, the stock underperformed its sector by 1.73%, hitting an intraday low of ₹2,100, which is also its new 52-week low. The share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend and weak momentum. Despite this, investor participation has increased, with delivery volumes rising by 13.73% against the five-day average, indicating heightened trading activity amid the price fall.

Financial Performance and Valuation Concerns

Colgate-Palmolive’s recent financial results have failed to inspire confidence among investors. The company reported flat results in the September 2025 quarter, with a quarterly profit after tax (PAT) of ₹327.51 crore, representing a 6.0% decline compared to the average of the previous four quarters. Additionally, the debtors turnover ratio for the half-year stood at a low 2.64 times, indicating potential inefficiencies in receivables management.

Over the last five years, the company’s net sales have grown at a modest annual rate of 5.28%, while operating profit has increased by 9.16% annually. These growth rates are relatively subdued for a consumer goods company, especially when compared to sector peers and broader market expectations. The stock’s return on equity (ROE) remains high at 73.11%, reflecting management efficiency, but this has not translated into commensurate share price appreciation.

Valuation metrics further dampen the outlook. The company’s price-to-book value stands at 36.1, which is considered very expensive despite being in line with historical peer valuations. This premium valuation is difficult to justify given the declining profits and weak share price performance. Over the past year, profits have fallen by 9.7%, while the stock has delivered a negative return of 27.48%, underscoring the disconnect between valuation and earnings growth.

Long-Term Underperformance and Market Sentiment

Colgate-Palmolive’s underwhelming performance is not limited to the short term. Over the past three years, the stock has generated a total return of 29.94%, which trails the Sensex’s 35.37% gain and the BSE500 index. Over five years, the stock’s 36.67% return pales in comparison to the Sensex’s 90.68% appreciation. This sustained underperformance has likely contributed to negative investor sentiment and selling pressure.

Despite the company’s strong institutional holding of 29.4%, which typically provides stability, the stock has struggled to maintain investor confidence. The low debt-to-equity ratio, effectively zero, indicates a conservative capital structure, but this has not been sufficient to offset concerns about growth and valuation.

Conclusion

The decline in Colgate-Palmolive (India) Ltd’s share price on 03-Dec is primarily driven by disappointing financial results, including falling profits and flat sales growth, combined with a valuation that appears stretched relative to earnings performance. The stock’s persistent underperformance against key benchmarks such as the Sensex and BSE500 over multiple time horizons has further eroded investor confidence. Trading below all major moving averages and hitting a new 52-week low signals continued bearish sentiment. While the company benefits from strong management efficiency and a conservative balance sheet, these positives have not been enough to counterbalance concerns about growth prospects and expensive valuation. Investors are likely reassessing their positions amid these challenges, contributing to the ongoing price weakness.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →